Role of Tzanck Smear in Determining Pemphigus Vulgaris Disease Activity
- Conditions
- Pemphigus Vulgaris
- Interventions
- Diagnostic Test: Tzanck smear
- Registration Number
- NCT05338112
- Lead Sponsor
- Istanbul Medeniyet University
- Brief Summary
Aim: Pemphigus vulgaris (PV) is a rare, life-threatening autoimmune bullous disease that can involve the skin and mucous membranes, characterized by intraepidermal bullae and eroded lesions caused by rupture of the bullae. The aim of this study is to research the relationship of the findings obtained with Tzanck smear, which is an inexpensive and easy method, with disease activity and its prognostic importance in the clinical course in PV patients.
Material and Methods: Pemphigus patients who visited to Goztepe Prof. Dr. Suleyman Yalcın City Hospital, Dermatology Clinic will be included in our study. Pemphigus disease area index (PDAI), Tzanck smear findings from the lesions and desmoglein levels during routine follow-up of patients with pemphigus vesicle/bulla/erosion will be evaluated. In the evaluation of Tzanck smear preparations, the entire slide will be scanned, acantholytic cell count performed and scored 1 to 4 accordingly (1 point: 1-3 cells, 2 points: 4-10 cells, 3 points:11-20, 4 points: \>21 cells or cell clusters). Anti-desmoglein antibody levels will be analyzed by using enzyme-linked immunosorbent assay (ELISA) method.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
- Clinical, histopathological and immunological diagnosis of pemphigus vulgaris
- Must be active bullae or erosion at any stage of the disease
- Patients with uncertain diagnosis of pemphigus vulgaris
- Eroded lesions due to causes other than pemphigus vulgaris (such as herpes in the oral mucosa, candida infection)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with active pemphigus lesions Tzanck smear -
- Primary Outcome Measures
Name Time Method The number of acantholytic cells 1or 2 months Tzanck smear slides will be entirely scanned, acantholytic cell count will be performed and scored 1 to 4 accordingly (1 point: 1-3 cells, 2 points: 4-10 cells, 3 points:11-20, 4 points: \>21 cells or cell clusters).
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Istanbul Medeniyet University
🇹🇷Istanbul, Turkey